This week, Vericel will be hosting a Fellows Webinar from 8-9 pm ET on November 20 to explore a knee cartilage repair procedure that uses a patient's own cells. Register here to learn more. https://lnkd.in/dsq8-mUh (For HCPs only)
Vericel? Corporation
生物技术研究
Cambridge，Massachusetts 15,746 位关注者
We are a leading provider of advanced therapies for the sports medicine and severe burn care markets.
关于我们
Vericel is a leading provider of advanced therapies for the sports medicine and severe burn care markets. The Company combines innovations in biology with medical technologies, resulting in a highly differentiated portfolio of innovative cell therapies and specialty biologics that repair injuries and restore lives. We currently market two autologous cell therapy products and one specialty biologic product in the United States. Personal integrity, teamwork, collaboration, and innovative technology are the foundations of our work. We seek to practice transparency in our clinical trials and research, and in our relationships with each other, our patients, and the investors who support us. PRIVACY AND COMMUNITY GUIDELINES When you engage with Vericel social media channels and our content providers on social media, you also agree to abide by the following Community Guidelines (found here: https://bit.ly/3pg3UKQ), which apply in addition to the Terms and Conditions or other legal notices specific to each social media channel. Please note that third-party social media channels also have access to information you share via social media. For more details, read LinkedIn's Privacy Policy here: https://bit.ly/3GF2r5Y. For additional information about privacy at Vericel, please see our Privacy Policy (bit.ly/43ErZcx) and Terms and Conditions of Use (bit.ly/4568Cdx). If you engage with us, you consent and give Vericel permission to communicate with you and to use any information, text and media associated with the interaction or post.
- 网站
-
https://www.vcel.com
Vericel? Corporation的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 总部
- Cambridge，Massachusetts
- 类型
- 上市公司
- 创立
- 1989
- 领域
- Biologics、Cell Therapy、Clinical Research、Multicellular Therapy Development、Clinical Trials和Automated cell-processing system
地点
Vericel? Corporation员工
-
Robert Walker
Regional Sales Director-West Region at Vericel Corporation
-
Patrick J. Fowler
Senior Vice President, Corporate Development and Strategy at Vericel Corporation
-
Eric Christianson
Medical Device Sales Director - High Performing Team Builder - Startup - Orthopedics - Pain Managment - Surgery- Burn
-
Keith Griesbaum
动态
-
Join Vericel? Burn Care for an American Burn Association webinar on best practices for the treatment of severe burns with cultured epidermal autografts. Speaker Arpana?Jain, MD, FACS?FABA, Associate Medical Director at the Diane and Bruce Halle?Arizona Burn Center – Valleywise Health will discuss the recent publication “Establishing Consensus of Best Practice for CEA Use in Treatment of Severe Burns: A US Burn Provider Delphi Study.” Register here: https://bit.ly/40KpB6e (For HCPs only) #BurnCare
-
-
Today we honor and recognize the brave men and women who have served our country. #VeteransDay
-
-
Will we see you at the Northeast Regional Burn Conference? Find our table for more information on Vericel? Burn Care’s therapies for the treatment of burns. More here: https://bit.ly/48lc6vi (For HCPs only) #BurnCare
-
-
Vericel Reports Third Quarter 2024 Financial Results: Total Revenue Growth of 27% to $57.9 Million https://lnkd.in/gr3eqXBV
-
-
Will we see you at the Pediatric Trauma Society Annual Meeting in Charlotte? Join Vericel? Burn Care’s lunch symposium on enzymatic eschar removal for pediatric patients. Register here: https://bit.ly/3Ur9dDt (For HCPs only) #BurnCare #PTS2024
-
-
Congratulations to Dr. Michael Kuhn at Middlesex Center for Advanced Orthopedic Surgery, LLC who recently treated his first patient arthroscopically using Vericel's newly approved MACI Arthro? instrumentation! Dr. Kuhn served as a key advisor in the development of our custom instrumentation, and we are proud to recognize this important milestone. ? Learn more about MACI Arthro here: https://bit.ly/3MsovU4
-
-
Last week our CEO Nick Colangelo sat down with Forbes reporter Alex Knapp to discuss the recent FDA approval of MACI Arthro and how it helps position the Company well for continued strong growth in the future. Read more: https://lnkd.in/gvsxJVuY
-
-
Vericel will be at the American Osteopathic Academy of Orthopedics Fall Annual Meeting next week. Find us at booth 209 to learn about an innovative approach to treating knee cartilage damage. https://lnkd.in/gv9ypAbx (For HCPs only) #AOAO
-